File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Transient hyperprolactinaemia in human menopausal gonadotropin induction of ovulation

TitleTransient hyperprolactinaemia in human menopausal gonadotropin induction of ovulation
Authors
Issue Date1984
Citation
International Journal Of Fertility, 1984, v. 29 n. 3, p. 136-140 How to Cite?
AbstractIn 20 anovulatory patients who were normoprolactinaemic, 12 developed transient hyperprolactinaemia when they were treated with human menopausal gonadotropin (hMG) for induction of ovulation. The hyperprolactinaemia was probably due to the increased oestrogen production effect on some susceptible patients. The pregnancy rate was found to be lower in those who developed this condition. The dosage of hMG required was found to be significantly higher in this group. The importance of recognizing this transient hyperprolactinaemia and probably the role of Bromocriptine are discussed. Further study is suggested.
Persistent Identifierhttp://hdl.handle.net/10722/173085
ISSN

 

DC FieldValueLanguage
dc.contributor.authorTang, GWKen_HK
dc.contributor.authorTang, LCHen_HK
dc.contributor.authorHo, PCen_HK
dc.date.accessioned2012-10-30T06:27:52Z-
dc.date.available2012-10-30T06:27:52Z-
dc.date.issued1984en_HK
dc.identifier.citationInternational Journal Of Fertility, 1984, v. 29 n. 3, p. 136-140en_HK
dc.identifier.issn0020-725Xen_HK
dc.identifier.urihttp://hdl.handle.net/10722/173085-
dc.description.abstractIn 20 anovulatory patients who were normoprolactinaemic, 12 developed transient hyperprolactinaemia when they were treated with human menopausal gonadotropin (hMG) for induction of ovulation. The hyperprolactinaemia was probably due to the increased oestrogen production effect on some susceptible patients. The pregnancy rate was found to be lower in those who developed this condition. The dosage of hMG required was found to be significantly higher in this group. The importance of recognizing this transient hyperprolactinaemia and probably the role of Bromocriptine are discussed. Further study is suggested.en_HK
dc.languageengen_US
dc.relation.ispartofInternational Journal of Fertilityen_HK
dc.subject.meshAdulten_US
dc.subject.meshAmenorrhea - Drug Therapyen_US
dc.subject.meshEstradiol - Blooden_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshMenotropins - Therapeutic Useen_US
dc.subject.meshMenstruation Disturbances - Drug Therapyen_US
dc.subject.meshOligomenorrhea - Drug Therapyen_US
dc.subject.meshOvulation Inductionen_US
dc.subject.meshProlactin - Blooden_US
dc.subject.meshTime Factorsen_US
dc.titleTransient hyperprolactinaemia in human menopausal gonadotropin induction of ovulationen_HK
dc.typeArticleen_HK
dc.identifier.emailTang, GWK: gwktang@hkucc.hku.hken_HK
dc.identifier.emailTang, LCH: lchtang@hku.hken_HK
dc.identifier.emailHo, PC: pcho@hku.hken_HK
dc.identifier.authorityTang, GWK=rp00328en_HK
dc.identifier.authorityTang, LCH=rp01756en_HK
dc.identifier.authorityHo, PC=rp00325en_HK
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.pmid6152248-
dc.identifier.scopuseid_2-s2.0-0021736641en_HK
dc.identifier.volume29en_HK
dc.identifier.issue3en_HK
dc.identifier.spage136en_HK
dc.identifier.epage140en_HK
dc.identifier.scopusauthoridTang, GWK=7401633864en_HK
dc.identifier.scopusauthoridTang, LCH=7402081111en_HK
dc.identifier.scopusauthoridHo, PC=7402211440en_HK

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats